Labcorp to Announce First Quarter Financial Results on April 30, 2026 Read more about Labcorp to Announce First Quarter Financial Results on April 30, 2026
Labcorp Completes Acquisition of Select Assets of Crouse Health’s Laboratory Alliance of Central New York’s Laboratory Business; Enters Agreement to Manage Crouse’s Inpatient Laboratory Read more about Labcorp Completes Acquisition of Select Assets of Crouse Health’s Laboratory Alliance of Central New York’s Laboratory Business; Enters Agreement to Manage Crouse’s Inpatient Laboratory
Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide Read more about Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide
Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease Assessment in Primary Care Read more about Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease Assessment in Primary Care
Labcorp Announces Multi-Year Partnership with SOMOS IPA to Expand Access to High Quality, Affordable Laboratory Services for Patients Across New York State Read more about Labcorp Announces Multi-Year Partnership with SOMOS IPA to Expand Access to High Quality, Affordable Laboratory Services for Patients Across New York State
Labcorp Completes Acquisition of Select Assets of Empire City Laboratories Read more about Labcorp Completes Acquisition of Select Assets of Empire City Laboratories
Labcorp Appoints John H. Sampson, M.D., Ph.D., to Board of Directors Read more about Labcorp Appoints John H. Sampson, M.D., Ph.D., to Board of Directors
Labcorp Named One of the World's Most Admired Companies™ by Fortune Read more about Labcorp Named One of the World's Most Admired Companies™ by Fortune
Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026 Read more about Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026
